等待开盘 09-23 09:30:00 美东时间
-0.010
-0.41%
Inspirato Incorporated and Buyerlink have mutually agreed to terminate their previously announced merger agreement, with Inspirato continuing to operate independently. The decision reflects the company's strengthened operational momentum, member engagement, and leadership in luxury travel. Inspirato's board concluded that remaining independent aligns with maximizing shareholder value while fostering brand growth and member experience. The company...
09-15 13:00
InspireMD, Inc. announced plans to present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025, at 10:00am ET. The presentation will cover the CGuard® Prime carotid stent system for stroke prevention. A live audio webcast and replay will be available on the company’s website.
08-27 13:00
Inspire Medical Systems announced that Chief Financial Officer Rick Buchholz will step down effective December 31, 2025, to pursue other opportunities. He will serve as a financial advisor until February 28, 2026, to ensure a smooth transition. Buchholz has significantly contributed to the company's growth since 2014, including revenue growth from $4 million to over $800 million and navigating challenges such as the COVID-19 pandemic. The company...
08-26 20:30
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Gainers Soligenix (NASDAQ:SNGX) shares rose 192.0% to $3.65 during Thursday's ...
08-01 01:08
InspireMD shares are trading higher after the company announced it has raised a...
07-31 23:09
InspireMD ( ($NSPR) ) just unveiled an update. On July 30, 2025, InspireMD ente...
07-31 20:58
InspireMD (NASDAQ:NSPR) raised ~$58M through a PIPE financing and warrant exercises. The $40.1M PIPE was led by OrbiMed and Marshall Wace, with participation from board members and other investors. 16...
07-31 20:46
InspireMD聘请Raymond W. Cohen为董事会成员,其拥有40年以上医疗科技领导经验,曾成功推动Axonics以37亿美元被Boston Scientific收购。InspireMD近期获FDA批准,即将推出CGuard Prime钴基颈动脉支架系统,Cohen的加入将助力公司加速商业化进程并提升长期价值。
07-31 12:31
InspireMD raised approximately $58 million through a PIPE financing and warrant exercises, triggered by FDA approval of its CGuard Prime carotid stent. The funding was led by investors OrbiMed and Marshall Wace, with proceeds aimed at strengthening the balance sheet and expanding commercial growth in the U.S. market. The company plans to use the funds for sales and marketing, R&D, and general corporate purposes, positioning itself to lead the car...
07-31 12:30